Economic impact of a modification of the treatment trajectories of patients with end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 30, Issue 12, 2015, Pages 2054-2068

  Couchoud, Cécile ^a   Couillerot, Anne Line ^b   Dantony, Emmanuelle ^c,d   Elsensohn, Mad Hélénie ^c,d   Labeeuw, Michel ^a   Villar, Emmanuel ^d,e   Ecochard, René ^c,d   Bongiovanni, Isabelle ^b  

^a AGENCE DE LA BIOMÉDECINE   (France)

^b Ancien Délégué Général de la Fédération de l'Hospitalisation Privée   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e Centre hospitalier Saint Luc et Saint Joseph   (France)

Author keywords

cost; dialysis; medico economic evaluation; simulation tool; transplantation

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; END STAGE RENAL DISEASE; HEALTH CARE COST; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; TREATMENT PLANNING; ADOLESCENT; COHORT ANALYSIS; COMPUTER SIMULATION; ECONOMICS; FEMALE; HEALTH SERVICE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; REGISTER; RENAL REPLACEMENT THERAPY; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; COMPUTER SIMULATION; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, STATISTICAL; REGISTRIES; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; YOUNG ADULT;

EID: 84949912173     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv300     Document Type: Article

References (21)

1. ERA EDTA registry. ERA-EDTA Registry Annual Report 2011. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2013
2. Couchoud C, Savoye E, Frimat L et al. Variability in case mix and peritoneal dialysis selection in fifty-nine French districts. Perit Dial Int 2008; 28: 509-517
3. REIN registry. Rapport annuel REIN 2012. http://www.agencebiomedecine. fr/Le-programme-REIN. 2014
4. Wong G, Howard K, Chapman JR et al. Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One 2012; 7: e29591
5. Couchoud C, Dantony E, Elsensohn MH et al. Modelling treatment trajectories to optimize the organization of renal replacement therapy and public health decision-making. Nephrol Dial Transplant 2013; 28: 2372-2382
6. Couchoud C, Stengel B, Landais P et al. The renal epidemiology and information network (REIN): A new registry for end-stage renal disease in France. Nephrol Dial Transplant 2006; 21: 411-418
7. Haute Autorité de Santé. Evaluation médico-économique des stratégies de prise en charge de linsuffisance rénale chronique terminale en France. http://www.has-sante.fr/portail/jcms/c-1776863/fr/insuffisance-renale-chroniqueterminale-comment-Ameliorer-lefficience-de-la-prise-en-charge. 2014
8. Chung R, Howard K, Craig JC et al. Economic evaluations in kidney transplantation: frequency, characteristics, and quality-A systematic review. Transplantation 2014; 97: 1027-1033
9. Bouvier N, Durand PY, Testa A et al. Regional discrepancies in peritoneal dialysis utilization in France: The role of the nephrologists opinion about peritoneal dialysis. Nephrol Dial Transplant 2009; 24: 1293-1297
10. Maaroufi A, Fafin C, Mougel S et al. Patients preferences regarding choice of end-stage renal disease treatment options. Am J Nephrol 2013; 37: 359-369
11. Jager KJ, Korevaar JC, Dekker FWet al. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis 2004; 43: 891-899
12. Little J, Irwin A, Marshall T et al. Predicting a patients choice of dialysis modality: experience in a United Kingdom renal department. Am J Kidney Dis 2001; 37: 981-986
13. Goovaerts T, Jadoul M, Goffin E. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Nephrol Dial Transplant 2005; 20: 1842-1847
14. Just PM, de Charro FT, Tschosik EA et al. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008; 23: 2365-2373
15. Chanouzas D, Ng KP, Fallouh B et al. What influences patient choice of treatment modality at the pre-dialysis stage? Nephrol Dial Transplant 2012; 27: 1542-1547
16. Morton RL, Tong A, Howard K et al. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ 2010; 340: c112
17. Chui BK, Manns B, Pannu N et al. Health care costs of peritoneal dialysis technique failure and dialysis modality switching. Am J Kidney Dis 2013; 61: 104-111
18. Treharne C, Liu FX, AriciMet al. Peritoneal dialysis and in-centre haemodialysis: A cost-utility analysis from a UK payer perspective. Appl Health Econ Health Policy 2014; 12: 409-420
19. Villa G, Fernandez-Ortiz L, Cuervo J et al. Cost-effectiveness analysis of the Spanish renal replacement therapy program. Perit Dial Int 2012; 32: 192-199
20. Liu FX, Treharne C, Culleton B et al. The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis. BMC Nephrol 2014; 15: 161
21. Laplante S, Krepel H, Simons B et al. Offering assisted peritoneal dialysis is a cost-effective alternative to the current care pathway in frail elderly Dutch patients. Int J Healthc Manag 2013; 6: 27-36